Skip to main content
. Author manuscript; available in PMC: 2020 Feb 20.
Published in final edited form as: J Allergy Clin Immunol Pract. 2018 Feb 6;6(5):1588–1595.e1. doi: 10.1016/j.jaip.2017.12.017

TABLE V.

Hazard ratios of asthma-related ED visits and hospitalizations associated with average DDD of statin use

Database Asthma-related ED visits or hospitalizations Asthma-related ED visits Asthma-related hospitalizations
Statin N Events AHR* (95% CI) Events AHR* (95% CI) Events AHR* (95% CI)
LHID2000+2005+2010
 0 (no use) 97,730 2,818 Ref 1,614 Ref 1,204 Ref
 1 (ave_DDD ≤ 0.67) 11,499 388 0.88 (0.79, 0.98) 203 0.92 (0.79, 1.07) 185 0.85 (0.73, 1)
 2 (ave_DDD > 0.67) 8,366 211 0.71 (0.61, 0.82) 119 0.79 (0.65, 0.95) 92 0.64 (0.52, 0.79)
LHID2000
 0 (no use) 35,265 1,102 Ref 609 Ref 493 Ref
 1 (ave_DDD ≤ 0.67) 3,985 132 0.96 (0.72, 1.3) 72 1.21 (0.78, 1.87) 60 0.82 (0.54, 1.23)
 2 (ave_DDD > 0.67) 2,863 83 0.9 (0.63, 1.28) 47 1.28 (0.79, 2.08) 36 0.65 (0.38, 1.1)
LHID2005
 0 (no use) 35,158 1,015 Ref 579 Ref 436 Ref
 1 (ave_DDD ≤ 0.67) 4,185 146 0.69 (0.49, 0.97) 73 0.75 (0.47, 1.2) 73 0.64 (0.39, 1.05)
 2 (ave_DDD > 0.67) 2,991 76 0.78 (0.54, 1.13) 49 1.04 (0.65, 1.68) 27 0.54 (0.29, 1)
LHID2010
 0 (no use) 31,512 829 Ref 501 Ref 328 Ref
 1 (ave_DDD ≤ 0.67) 3,814 126 1 (0.7, 1.42) 70 1.2 (0.71, 2.02) 56 0.88 (0.55, 1.41)
 2 (ave_DDD > 0.67) 2,815 62 0.71 (0.46, 1.11) 28 0.87 (0.46, 1.64) 34 0.61 (0.33, 1.14)

AHR, Adjusted hazards ratio; ave_DDD, average DDD; CI, confidence interval; DDD, defined daily dose; ED, emergency department; LHID, Longitudinal Health Insurance Database.

*

Adjusted for age, sex, Deyo-Charlson index (exclude chronic pulmonary disease) in the 12 mo before the index date, asthma controller medication in the 12 mo before the index date, diagnosis of asthma in the 12 mo before the index date, and health care utilization in the 12 mo before the index date.

Significant results (P < .05) are in bold.